- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Oncology
Volume 2010 (2010), Article ID 659231, 7 pages
Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas
1Arthur & Sonia Labatts Brain Tumor Center, Hospital for Sick Children, University of Toronto, Toronto, Canada M5G 2G4
2Department of Pathology, Western Hospital, University of Toronto, Toronto, Canada M5G 2G4
3Division of Neurosurgery, Western Hospital, University of Toronto, Toronto, Canada M5G 2G4
Received 13 December 2009; Accepted 15 February 2010
Academic Editor: Arkadiusz Dudek
Copyright © 2010 Gelareh Zadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- I. Kim, J.-H. Kim, S.-O. Moon, H. J. Kwak, N.-G. Kim, and G. Y. Koh, “Angiopoietin-2 at high concentration can enhance enthelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway,” Oncogene, vol. 19, no. 39, pp. 4549–4552, 2000.
- P. C. Maisonpierre, C. Suri, P. F. Jones, et al., “Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis,” Science, vol. 277, no. 5322, pp. 55–60, 1997.
- W. S. Moon, K. H. Rhyu, M. J. Kang, et al., “Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?” Modern Pathology, vol. 16, no. 6, pp. 552–557, 2003.
- K. Teichert-Kuliszewska, P. C. Maisonpierre, N. Jones, et al., “Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2,” Cardiovascular Research, vol. 49, no. 3, pp. 659–670, 2001.
- R. P. Visconti, C. D. Richardson, and T. N. Sato, “Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF),” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8219–8224, 2002.
- N. L. Ward and D. J. Dumont, “The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development,” Seminars in Cell and Developmental Biology, vol. 13, no. 1, pp. 19–27, 2002.
- G. Zadeh and A. Guha, “Molecular regulators of angiogenesis in the developing nervous system and adult brain tumors (review),” International Journal of Oncology, vol. 23, no. 3, pp. 557–565, 2003.
- Q. Yu and I. Stamenkovic, “Angiopoietin-2 is implicated in the regulation of tumor angiogenesis,” American Journal of Pathology, vol. 158, no. 2, pp. 563–570, 2001.
- T. Etoh, H. Inoue, S. Tanaka, G. F. Barnard, S. Kitano, and M. Mori, “Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases,” Cancer Research, vol. 61, no. 5, pp. 2145–2153, 2001.
- A. Stratmann, T. Acker, A. M. Burger, K. Amann, W. Risau, and K. H. Plate, “Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants,” International Journal of Cancer, vol. 91, no. 3, pp. 273–282, 2001.
- K. Koga, T. Todaka, M. Morioka, et al., “Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis,” Cancer Research, vol. 61, no. 16, pp. 6248–6254, 2001.
- G. Zadeh and A. Guha, “Neoangiogenesis in human astrocytomas: expression and functional role of angiopoietins and their cognate receptors,” Frontiers in Bioscience, vol. 8, pp. e128–e137, 2003.
- B. Hu, P. Guo, Q. Fang, et al., “Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8904–8909, 2003.
- L. Chen, Z. Yang, G. Wang, and C. Wang, “Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma,” Journal of Tongji Medical University, vol. 21, no. 3, pp. 228–230, 2001.
- L. F. Brown, B. J. Dezube, K. Tognazzi, H. F. Dvorak, and G. D. Yancopoulos, “Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma,” American Journal of Pathology, vol. 156, no. 6, pp. 2179–2183, 2000.
- L. M. Ellis, S. Ahmad , F. Fan, et al., “Angiopoietins and their role in colon cancer angiogenesis,” Oncology (Huntingt), vol. 16, no. 4, supplement 3, pp. 31–35, 2002.
- H. Ding, L. Roncari, X. Wu, et al., “Expression and hypoxic regulation of angiopoietins in human astrocytomas,” Neuro-Oncology, vol. 3, no. 1, pp. 1–10, 2001.
- I. Fischer, J.-P. Gagner, M. Law, E. W. Newcomb, and D. Zagzag, “Angiogenesis in gliomas: biology and molecular pathophysiology,” Brain Pathology, vol. 15, no. 4, pp. 297–310, 2005.
- O. H. Lee, J. Fueyo, J. Xu, et al., “Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth,” Neoplasia, vol. 8, no. 5, pp. 419–428, 2006.
- A. Stratmann, W. Risau, and K. H. Plate, “Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis,” American Journal of Pathology, vol. 153, no. 5, pp. 1459–1466, 1998.
- S. Wang, A. Khan, F. F. Lang, and T. S. Schaefer, “Conditional gene expression in human intracranial xenograft tumors,” BioTechniques, vol. 31, no. 1, pp. 196–202, 2001.
- D. Zagzag, A. Hooper, D. R. Friedlander, et al., “In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis,” Experimental Neurology, vol. 159, no. 2, pp. 391–400, 1999.
- J. Holash, P. C. Maisonpierre, D. Compton, et al., “Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF,” Science, vol. 284, no. 5422, pp. 1994–1998, 1999.
- D. Zagzag, R. Amirnovin, M. A. Greco, et al., “Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis,” Laboratory Investigation, vol. 80, no. 6, pp. 837–849, 2000.